Condition
Middle Cerebral Artery Aneurysm
Total Trials
4
Recruiting
1
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 4 (1)
Trial Status
Completed1
Unknown1
Not Yet Recruiting1
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05161377Not ApplicableRecruitingPrimary
Middle Cerebral Artery Aneurysm Trial
NCT07372612Phase 4Not Yet Recruiting
Flow-diverting Devices for the Treatment of Middle Cerebral Artery Bifurcation Aneurysms
NCT04927520UnknownPrimary
Prospective, Multicenter Cohort Study on the Safety and Efficacy of Treatment for Middle Cerebral Artery Aneurysms
NCT03493035CompletedPrimary
Risk Factors of Middle Cerebral Artery Aneurysm.
Showing all 4 trials